Evidence map›Paper›PMID 32716695›Full record

ReviewCirculation research2020

Emerging Technologies for Identifying Atrial Fibrillation.

Eric Y Ding, Gregory M Marcus, David D McManus

Abstract readReview
In one paragraph

Review in Circulation research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Symptom severity assessment in patients with atrial fibrillation after catheter ablation using a smartphone application.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2026
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Observational
  12. Screening and diagnosis of atrial fibrillation using wearable devices.The Korean journal of internal medicine · 2025
    Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Eric Y DingFrom the Department of Population and Quantitative Health Sciences and Division of Cardiology, Department of Medicine, University of Massachusetts Medical School (E.Y.D., D.D.M.).
Gregory M MarcusDivision of Cardiology, Department of Medicine, University of California, San Francisco (G.M.M.).
David D McManusFrom the Department of Population and Quantitative Health Sciences and Division of Cardiology, Department of Medicine, University of Massachusetts Medical School (E.Y.D., D.D.M.).

Funding

The Center for Advancing Point of Care in Heart, Lung, Blood and Sleep DiseasesU54HL143541 · NHLBI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Nathaniel Scott Hafer · 2018 to 2026
$141.0M
RURAL: Risk Underlying Rural Areas Longitudinal Cohort StudyU01HL146382 · NHLBI · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI JUDD, SUZANNE E, RAMACHANDRAN, VASAN · 2019 to 2025
$42.5M
Mechanistic Relationships Between Ethanol and Human Atrial FibrillationR01AA022222 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GREGORY M MARCUS · 2014 to 2026
$4.4M
Transdisciplinary Training In Cardiovascular ResearchT32HL120823 · NHLBI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI DONAHUE, J KEVIN, KIEFE, CATARINA I. · 2014 to 2025
$3.9M
Detecting bleeding events using EHRs for prediction in AfibR01HL137794 · NHLBI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MCMANUS, DAVID D., YU, HONG · 2018 to 2021
$3.3M
Systematic Assessment of Geriatric Elements in Atrial Fibrillation (SAGE-AF)R01HL126911 · NHLBI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI MCMANUS, DAVID D., SACZYNSKI, JANE STEELE · 2016 to 2019
$3.2M
Community Surveillance of Coronary Heart DiseaseR01HL135219 · NHLBI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI GOLDBERG, ROBERT JOEL, YU, HONG · 2017 to 2020
$3.2M
Smartwatch Monitoring for Atrial Fibrillation After StrokeR01HL137734 · NHLBI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CHON, KI H, MCMANUS, DAVID D. · 2018 to 2021
$3.1M
Automated detection and prediction of atrial fibrillation during sepsisR01HL136660 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI WALKEY, ALLAN J. · 2017 to 2020
$2.2M
Feasibility of Smartwatches for Atrial Fibrillation Detection in Older AdultsF30HL149335 · NHLBI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI DING, ERIC YUXIAO · 2019 to 2021
$92k
NHLBI NIH HHS F30 HL149335NHLBI NIH HHS R01 HL126911NHLBI NIH HHS R01 HL135219NHLBI NIH HHS R01 HL136660NHLBI NIH HHS R01 HL137734NHLBI NIH HHS R01 HL137794NHLBI NIH HHS T32 HL120823NHLBI NIH HHS U01 HL146382NHLBI NIH HHS U54 HL143541NIAAA NIH HHS R01 AA022222
6 · The paper itself

Abstract

Atrial fibrillation (AF) is a major cause of morbidity and mortality globally, and much of this is driven by challenges in its timely diagnosis and treatment. Existing and emerging mobile technologies have been used to successfully identify AF in a variety of clinical and community settings, and while these technologies offer great promise for revolutionizing AF detection and screening, several major barriers may impede their effectiveness. The unclear clinical significance of device-detected AF, potential challenges in integrating patient-generated data into existing healthcare systems and clinical workflows, harm resulting from potential false positives, and identifying the appropriate scope of population-based screening efforts are all potential concerns that warrant further investigation. It is crucial for stakeholders such as healthcare providers, researchers, funding agencies, insurers, and engineers to actively work together in fulfilling the tremendous potential of mobile technologies to improve AF identification and management on a population level.

Indexed as

Atrial FibrillationComputers, HandheldElectrocardiographyHeart Rate DeterminationHumansWearable Electronic Devicesatrial fibrillationdirect-to-consumer screeningelectrocardiographyFood and Drug Administration device approvalmedical deviceswearable devices

Identifiers

PMID32716695
PMCPMC8386822

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.